{"DataElement":{"publicId":"3894915","version":"1","preferredName":"Contralateral Breast Malignant Neoplasm Histologic Assessment Type","preferredDefinition":"The type related to the histologic assessment of a malignant neoplasm in the contralateral breast.","longName":"CBREASTHIST","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"3894899","version":"1","preferredName":"Contralateral Breast Malignant Neoplasm Histologic Assessment","preferredDefinition":"Information related to the histologic assessment of a malignant neoplasm in the contralateral breast.","longName":"CBREASTHIST","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2732173","version":"1","preferredName":"Contralateral Breast Malignant Neoplasm","preferredDefinition":"On or relating to the opposite side (of the body):One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25307:C12971:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contralateral","conceptCode":"C25307","definition":"On or relating to the opposite side of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"472980C3-7BB7-03E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-02-27","modifiedBy":"ONEDATA","dateModified":"2008-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3321256","version":"1","preferredName":"Histologic Assessment","preferredDefinition":"Of or relating to histology.:Having determined the value, significance, or extent of.","longName":"C25526:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B35D4DE2-7D61-DF95-E040-BB89AD432B3E","latestVersionIndicator":"Yes","beginDate":"2011-12-05","endDate":null,"createdBy":"REBOYJ","dateCreated":"2011-12-05","modifiedBy":"ONEDATA","dateModified":"2011-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6313229-2D92-D2B1-E040-BB89AD430286","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to Alliance for by script Fri Oct 25 15:25:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3894913","version":"1","preferredName":"Breast Malignant Neoplasm Histologic Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"BREASTBEHAVIOR","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Invasive","valueDescription":"Invasive","ValueMeaning":{"publicId":"2575198","version":"1","preferredName":"Invasive","longName":"2575198","preferredDefinition":"Marked by a tendency to spread especially into healthy tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F2CB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-24","modifiedBy":"CURTIST","dateModified":"2007-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6313229-2DB8-D2B1-E040-BB89AD430286","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"ONEDATA","dateModified":"2013-09-12","deletedIndicator":"No"},{"value":"DCIS","valueDescription":"Ductal Carcinoma In Situ","ValueMeaning":{"publicId":"3262799","version":"1","preferredName":"Ductal Carcinoma In Situ","longName":"3262799","preferredDefinition":"A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAB50210-A094-7298-E040-BB89AD4308A3","latestVersionIndicator":"Yes","beginDate":"2011-08-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6313229-2DC3-D2B1-E040-BB89AD430286","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"ONEDATA","dateModified":"2013-09-12","deletedIndicator":"No"},{"value":"LCIS","valueDescription":"Lobular Carcinoma In Situ","ValueMeaning":{"publicId":"3251341","version":"1","preferredName":"Lobular Carcinoma In Situ","longName":"3251341","preferredDefinition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-9DB9-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6313229-2DCE-D2B1-E040-BB89AD430286","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"ONEDATA","dateModified":"2013-09-12","deletedIndicator":"No"},{"value":"Benign","valueDescription":"Benign","ValueMeaning":{"publicId":"3238719","version":"1","preferredName":"Benign","longName":"3238719","preferredDefinition":"(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A41FA3DD-96AA-2446-E040-BB89AD43483C","latestVersionIndicator":"Yes","beginDate":"2011-05-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6313229-2DD9-D2B1-E040-BB89AD430286","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"ONEDATA","dateModified":"2013-09-12","deletedIndicator":"No"},{"value":"No known abnormality","valueDescription":"No Known Abnormality","ValueMeaning":{"publicId":"3894914","version":"1","preferredName":"No Known Abnormality","longName":"3894914","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Recognized, familiar, or within the scope of knowledge.: A condition that differs from the usual physical or mental state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Known","conceptCode":"C80137","definition":"Recognized, familiar, or within the scope of knowledge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6313229-2DE8-D2B1-E040-BB89AD430286","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6313229-2E01-D2B1-E040-BB89AD430286","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"ONEDATA","dateModified":"2013-09-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6313229-2DA4-D2B1-E040-BB89AD430286","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"PWEST","dateModified":"2014-02-05","changeDescription":" Changed from CTEP to Alliance for by script Fri Oct 25 15:25:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CBREASTHIST","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Contralateral breast most ext","type":"Preferred Question Text","description":"Contralateral breast most extensive behavior","url":null,"context":"CTEP"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6313229-2E14-D2B1-E040-BB89AD430286","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-09-12","modifiedBy":"FORMBUILDER","dateModified":"2014-07-14","changeDescription":" Changed from CTEP to Alliance for by script Fri Oct 25 15:25:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}